医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2013年
12期
2298-2301
,共4页
田鑫%邹惠%贺湘玲%杨曼琼%邹润英
田鑫%鄒惠%賀湘玲%楊曼瓊%鄒潤英
전흠%추혜%하상령%양만경%추윤영
白血病%RNA ,信使
白血病%RNA ,信使
백혈병%RNA ,신사
Leukemia%RNA,Messenger
[目的]了解脆性组氨酸三联体(fragile histidine triad ,FHIT )基因在儿童白血病中的表达,分析FHIT基因与儿童白血病的关系;探讨FHIT基因在儿童白血病中的发病机制。[方法]收集本院2009年1月至2011年3月白血病的儿童51例作为白血病组,同期本院非白血病儿童10例作为对照组,检测两组儿童骨髓单个核细胞(Bone marrow mononuclear cells ,BMMCs)中FHIT基因的mRNA表达。[结果]白血病组FHIT mRNA表达阳性率明显低于对照组(54.90% vs 100.00%,P <0.05);白血病缓解组FHIT mRNA表达阳性率为66.67%,对照组FHIT mRNA表达阳性率为100.00%,两组间无明显差异( P>0.05);白血病组FHIT mRNA表达阳性率在不同性别、年龄、白血病类型、治疗阶段组别间无显著差异( P>0.05);高肿瘤负荷组FHIT mR-NA表达阳性率明显低于低肿瘤负荷组(33.33% vs 66.67%,P<0.05)。[结论]FHIT mRNA在儿童白血病中低表达;FHIT mRNA表达阳性率在不同性别、年龄、白血病类型、治疗阶段的白血病儿童间无差异;高肿瘤负荷的白血病患儿 FHIT mRNA表达阳性率低于低肿瘤负荷患儿。
[目的]瞭解脆性組氨痠三聯體(fragile histidine triad ,FHIT )基因在兒童白血病中的錶達,分析FHIT基因與兒童白血病的關繫;探討FHIT基因在兒童白血病中的髮病機製。[方法]收集本院2009年1月至2011年3月白血病的兒童51例作為白血病組,同期本院非白血病兒童10例作為對照組,檢測兩組兒童骨髓單箇覈細胞(Bone marrow mononuclear cells ,BMMCs)中FHIT基因的mRNA錶達。[結果]白血病組FHIT mRNA錶達暘性率明顯低于對照組(54.90% vs 100.00%,P <0.05);白血病緩解組FHIT mRNA錶達暘性率為66.67%,對照組FHIT mRNA錶達暘性率為100.00%,兩組間無明顯差異( P>0.05);白血病組FHIT mRNA錶達暘性率在不同性彆、年齡、白血病類型、治療階段組彆間無顯著差異( P>0.05);高腫瘤負荷組FHIT mR-NA錶達暘性率明顯低于低腫瘤負荷組(33.33% vs 66.67%,P<0.05)。[結論]FHIT mRNA在兒童白血病中低錶達;FHIT mRNA錶達暘性率在不同性彆、年齡、白血病類型、治療階段的白血病兒童間無差異;高腫瘤負荷的白血病患兒 FHIT mRNA錶達暘性率低于低腫瘤負荷患兒。
[목적]료해취성조안산삼련체(fragile histidine triad ,FHIT )기인재인동백혈병중적표체,분석FHIT기인여인동백혈병적관계;탐토FHIT기인재인동백혈병중적발병궤제。[방법]수집본원2009년1월지2011년3월백혈병적인동51례작위백혈병조,동기본원비백혈병인동10례작위대조조,검측량조인동골수단개핵세포(Bone marrow mononuclear cells ,BMMCs)중FHIT기인적mRNA표체。[결과]백혈병조FHIT mRNA표체양성솔명현저우대조조(54.90% vs 100.00%,P <0.05);백혈병완해조FHIT mRNA표체양성솔위66.67%,대조조FHIT mRNA표체양성솔위100.00%,량조간무명현차이( P>0.05);백혈병조FHIT mRNA표체양성솔재불동성별、년령、백혈병류형、치료계단조별간무현저차이( P>0.05);고종류부하조FHIT mR-NA표체양성솔명현저우저종류부하조(33.33% vs 66.67%,P<0.05)。[결론]FHIT mRNA재인동백혈병중저표체;FHIT mRNA표체양성솔재불동성별、년령、백혈병류형、치료계단적백혈병인동간무차이;고종류부하적백혈병환인 FHIT mRNA표체양성솔저우저종류부하환인。
[Objective]To understand the expression of fragile histidine triad (FHIT ) in childhood leukemia ,and to analyze the relationship between FHIT and childhood leukemia ,and to explore the role of FHIT in the pathogene-sis of childhood leukemia .[Methods] A total of 51 pediatric patients with leukemia from Jan .2009 to March 2011 were collected as leukemia group .Other 10 children without leukemia during the same period were collected from Hu-nan provincial people's hospital as the control group .The expression of FHIT mRNA in bone marrow mononuclear cells(BMMCs) of two groups was detected .[Results]The positive rate of FHIT mRNA in leukemia group was obvi-ously lower than that in control group (54 .90% vs 100 .00% ,P<0 .05) .There was no significant difference in the positive rate of FHIT mRNA between leukemia remission group and control group (66 .67% vs 100 .00% , P >0 .05) .There was no significant difference in the positive rate of FHIT mRNA among leukemia groups with different sex ,age ,leukemia type and treatment phase ( P > 0 .05) .The positive rate of FHIT mRNA in high tumor load group was obviously lower than that in low tumor load group (33 .33% vs 66 .67% ,P<0 .05) .[Conclusion]Pediat-ric patients with leukemia have low expression of FHIT mRNA .There is no significant difference in the positive rate of FHIT mRNA among leukemia patients with different sex ,age ,leukemia type and treatment phase .The positive rate of FHIT mRNA in leukemia patients with high tumor load is lower than that in leukemia patients with low tumor load .